Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 5, 2012, Pages 590-595

  Mucksavage, Phillip ^a   Mitchell, Christopher ^a   Kutikov, Alexander ^a   Wein, Alan J ^a   Torigian, Drew ^a   Malkowicz, S Bruce ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anthropometric; Biochemical failure; Obesity; Prostate cancer; Radical retropubic prostatectomy; Superficial fat; Visceral fat

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BIOCHEMICAL FAILURE FREE SURVIVAL; BODY FAT DISTRIBUTION; BODY MASS; CANCER GROWTH; CANCER SURVIVAL; FOLLOW UP; GLEASON SCORE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; RETROSPECTIVE STUDY; THICKNESS;

AGED; ANTHROPOMETRY; BODY MASS INDEX; BODY WEIGHT; DATABASES, FACTUAL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; INTRA-ABDOMINAL FAT; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84866757874     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.07.007     Document Type: Article

References (24)

1. Renehan A.G., Tyson M., Egger M., et al. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
2. Banez L.L., Sun L., Trock B.J., et al. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. Urol 2009, 182:491-496.
3. Eden C.G., Chang C.M., Gianduzzo T., et al. The impact of obesity on laparoscopic radical prostatectomy. BJU Int 2006, 98:1279-1282.
4. Freedland S.J., Sun L., Kane C.J., et al. Obesity and oncologic outcome after radical prostatectomy: Impact of prostate-specific antigen-based prostate cancer screening: Results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases. BJU International 2008, 102:969-974.
5. Mallah K.N., DiBlasio C.J., Rhee A.C., et al. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 2005, 103:2030-2034.
6. Jayachandran J., Banez L.L., Jaronson W., et al. Obesity as a predictor of adverse outcome across black and white race: Results from the search and Duke Prostate Center databases. J Urol 2008, 179. 647-7.
7. Buschemeyer W.C., Freedland S.J. Obesity and prostate cancer: Epidemiology and clinical implications. Eur Urol 2007, 52:331-343.
8. Ludescher B., Machann J., Eschweiler G.W., et al. Correlation of fat distribution in whole body MRI with generally used anthropometric data. Invest Radiol 2009, 44:712-719.
9. Schoen R.E., Thaete F.L., Sankey S.S., et al. Sagittal diameter in comparison with single slice CT as a predictor of total visceral adipose tissue volume. Int J Obes 1998, 22:338-342.
10. van Roermund J.G.H., Witjes J.A. The impact of obesity on prostate cancer. World J Urol 2007, 25:491-497.
11. Amling C.L., Riffenburgh R.H., Sun L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Urol 2004, 171:116-117.
12. Fitzsimons N.J., Sun L.L., Dahm P., et al. A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathologic outcomes for obese men: An analysis of the Duke Prostate Center database. Urology 2007, 70:1146-1151.
13. Freedland S.J., Grubb K.A., Yiu S.K., et al. Obesity and capsular incision at the time of open retropubic radical prostatectomy. J Urol 2005, 174:1798-1801.
14. Siddiqui S.A., Inman B.A., Sengupta S., et al. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer 2006, 107:521-529.
15. Shuldiner A.R., Yang R.Z., Gong D.W. Resistin, obesity, and insulin resistance-the emerging role of the adipocyte as an endocrine organ. New Engl J Med 2001, 345:1345-1346.
16. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocrine Rev 2000, 21:697-738.
17. Despres J.P. Is visceral obesity the cause of the metabolic syndrome?. Ann Med 2006, 38:52-63.
18. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor I and prostate cancer risk: A prospective study. Science 1998, 279:563-566.
19. Baillargeon J., Platz E.A., Rose D.P., et al. Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol Biomarkers Prev 2006, 15:1331-1335.
20. Gann P.H., Hennekens C.H., Longcope C., et al. A prospective study of plasma-hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995, 26:40-49.
21. Ronnemaa T., Karonen S.L., Rissanen A., et al. Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Ann Int Med 1997, 126:26-31.
22. Gallina A., Karakiewicz P.I., Hutterer G.C., et al. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int J Cancer 2007, 121:791-795.
23. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83:847-850.
24. von Hafe P., Pina F., Perez A., et al. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004, 12:1930-1935.